tradingkey.logo
tradingkey.logo
Search

Viridian Therapeutics Inc

VRDN
Add to Watchlist
19.890USD
+0.010+0.05%
Close 07-30 16:00ETQuotes delayed by 15 min
2.04BMarket Cap
LossP/E TTM

VRDN Financials

See Viridian Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Viridian Therapeutics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-1.03/-1.09
Revenue / Forecast
141.00K/27.50K
Period
FY2025 Earnings
Revenue(YoY)
70.85M
23359.93%
EPS(YoY)
-4.04
-1.60%
Analyst Rating
BUY
2026/07/30
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
3.94%-1.03
-28.05%-1.27
63.36%-0.42
-21.30%-1.23
-34.48%-1.07
25.83%-0.99
-5.76%-1.15
20.05%-1.02
50.76%-0.79
-19.04%-1.34
---1.09
---1.27
---1.61
---1.13
---2.88
----
----
----
----
----
Revenue
95.83%141.00K
83.33%132.00K
81958.14%70.57M
4.17%75.00K
0.00%72.00K
0.00%72.00K
19.44%86.00K
0.00%72.00K
-26.53%72.00K
-31.43%72.00K
-93.97%72.00K
-71.88%72.00K
-54.63%98.00K
-50.93%105.00K
474.52%1.20M
-76.51%256.00K
-85.11%216.00K
296.30%214.00K
--208.00K
548.81%1.09M
Net Profit
-20.70%-104.90M
-50.96%-120.36M
54.88%-34.60M
-54.99%-100.73M
-79.04%-86.91M
-19.24%-79.72M
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-58.17%-45.78M
-105.83%-28.91M
-64.17%-29.49M
-39.18%-25.69M
68.10%-28.95M
-155.61%-14.04M
-179.16%-17.96M
Net Margin
38.37%-74397.87%
17.66%-91178.03%
99.95%-49.03%
-48.79%-134313.33%
-79.04%-120711.11%
-19.24%-110729.17%
-34.71%-89173.26%
-18.03%-90268.06%
3.05%-67419.44%
-112.96%-92861.11%
---66194.44%
---76476.39%
---69541.84%
---43604.76%
---5044.33%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
250.43%10.97%
237.61%9.36%
36.14%3.62%
2.23%3.57%
-2.95%3.13%
-32.71%2.77%
-56.30%2.66%
160.63%3.49%
166.58%3.22%
285.91%4.12%
--6.08%
--1.34%
--1.21%
--1.07%
--1.05%
----
----
----
----
----
Revenue
95.83%141.00K
83.33%132.00K
81958.14%70.57M
4.17%75.00K
0.00%72.00K
0.00%72.00K
19.44%86.00K
0.00%72.00K
-26.53%72.00K
-31.43%72.00K
-93.97%72.00K
-71.88%72.00K
-54.63%98.00K
-50.93%105.00K
474.52%1.20M
-76.51%256.00K
-85.11%216.00K
296.30%214.00K
--208.00K
548.81%1.09M
Operating profit
-23.76%-116.17M
-40.33%-122.75M
52.07%-40.01M
-47.90%-106.77M
-67.93%-93.87M
-22.38%-87.47M
-62.97%-83.48M
-21.78%-72.19M
22.87%-55.90M
-45.68%-71.48M
-71.98%-51.22M
-100.50%-59.27M
-179.94%-72.47M
-68.72%-49.07M
-110.73%-29.79M
-64.26%-29.56M
-39.83%-25.89M
-40.41%-29.08M
-165.33%-14.13M
-185.64%-18.00M
Net Profit
-20.70%-104.90M
-50.96%-120.36M
54.88%-34.60M
-54.99%-100.73M
-79.04%-86.91M
-19.24%-79.72M
-60.91%-76.69M
-18.03%-64.99M
28.77%-48.54M
-46.03%-66.86M
-64.88%-47.66M
-86.71%-55.06M
-165.25%-68.15M
-58.17%-45.78M
-105.83%-28.91M
-64.17%-29.49M
-39.18%-25.69M
68.10%-28.95M
-155.61%-14.04M
-179.16%-17.96M
Current assets
19.40%784.74M
21.09%894.23M
-25.47%571.91M
-0.50%578.75M
4.85%657.24M
51.80%738.46M
136.96%767.36M
67.95%581.66M
63.83%626.82M
12.83%486.48M
-25.96%323.84M
108.44%346.33M
113.28%382.60M
115.41%431.17M
100.68%437.36M
43.90%166.15M
47.60%179.39M
54.43%200.16M
581.66%217.94M
255.04%115.46M
Total current liabilities
53.60%51.80M
47.67%70.70M
22.56%50.70M
43.04%52.59M
29.09%33.73M
79.74%47.87M
77.93%41.36M
28.28%36.76M
-11.70%26.13M
-20.13%26.64M
-7.80%23.25M
33.99%28.66M
105.67%29.59M
144.57%33.35M
75.84%25.21M
27.08%21.39M
-12.47%14.39M
27.75%13.64M
89.72%14.34M
150.33%16.83M
Total assets
19.37%789.02M
21.15%899.42M
-25.23%577.14M
-0.57%582.32M
4.85%660.98M
51.38%742.40M
134.79%771.90M
66.63%585.66M
63.04%630.38M
12.72%490.42M
-25.38%328.76M
106.97%351.47M
111.09%386.64M
113.58%435.09M
99.17%440.58M
43.66%169.81M
49.12%183.16M
55.20%203.71M
573.73%221.21M
253.00%118.20M
Total liabilities
170.77%153.01M
150.48%177.25M
15.16%74.17M
19.23%67.16M
18.09%56.51M
46.20%70.76M
42.55%64.40M
58.17%56.33M
32.58%47.85M
20.92%48.40M
43.10%45.18M
27.56%35.61M
118.44%36.09M
150.28%40.03M
90.04%31.57M
44.72%27.92M
-1.85%16.52M
42.57%15.99M
40.90%16.61M
56.65%19.29M
Total equity
5.22%636.01M
7.52%722.17M
-28.91%502.97M
-2.68%515.17M
3.77%604.47M
51.95%671.64M
149.49%707.50M
67.59%529.34M
66.18%582.53M
11.89%442.02M
-30.67%283.58M
122.59%315.86M
110.36%350.55M
110.46%395.06M
99.91%409.01M
43.46%141.90M
57.21%166.64M
56.38%187.72M
872.30%204.59M
367.21%98.91M
Net operating income
-29.14%-119.65M
67.61%-23.75M
-24.97%-84.61M
-63.65%-75.37M
-104.88%-92.65M
-92.98%-73.33M
-73.68%-67.71M
-1.87%-46.06M
27.03%-45.22M
-11.63%-38.00M
-88.62%-38.98M
-149.99%-45.21M
-194.52%-61.97M
-105.87%-34.04M
-74.05%-20.67M
-23.61%-18.09M
-82.36%-21.04M
-75.24%-16.54M
-133.07%-11.88M
-115.51%-14.63M
Net investment
-22.79%77.26M
-439.49%-339.42M
248.91%126.08M
22.17%75.72M
169.95%100.06M
62.93%-62.91M
-276.24%-84.67M
52.23%61.98M
-975.93%-143.04M
6.03%-169.71M
12.64%48.04M
191.58%40.71M
-250.01%-13.29M
-125.16%-180.60M
582.31%42.65M
224.61%13.96M
-18.48%8.86M
-52.99%-80.21M
11894.34%6.25M
---11.21M
Net financing
-30.99%6.36M
1042.63%405.91M
-95.57%10.86M
607.41%764.00K
-94.80%9.21M
-82.14%35.52M
1485.19%245.02M
-96.48%108.00K
2058.48%177.08M
664.75%198.94M
-94.69%15.46M
-32.69%3.07M
1011.65%8.20M
15202.35%26.01M
149.10%290.93M
-35.37%4.56M
-41.38%738.00K
-99.78%170.00K
2414.40%116.79M
456.15%7.05M

FAQs

What is the total revenue of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its total revenue reached 70.85M, with a year-on-year change of 302.00K.

What are the current assets of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its current assets were 894.23M, with a year-on-year change of 21.09.

What are the total assets of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its total assets of Viridian Therapeutics Inc were 899.42M, with a year-on-year change of 21.15.

What are the total liabilities of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its total liabilities of Viridian Therapeutics Inc were 177.25M, with a year-on-year change of 150.48.

What is the total equity of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its total equity of Viridian Therapeutics Inc was 722.17M, with a year-on-year change of 7.52.

What is the net operating income of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its net operating income of Viridian Therapeutics Inc was -324.92M, with a year-on-year change of -8.66.

What is the net investment of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its net investment of Viridian Therapeutics Inc was -37.56M, with a year-on-year change of 83.57.

What is the net financing of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its net financing of Viridian Therapeutics Inc was 426.74M, with a year-on-year change of -6.77.

What is the Earnings Per Share (EPS) of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.04, with a year-on-year change of -1.60.

What is the net income of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its net income was -342.60M, with a year-on-year change of -26.91.

What is the net margin of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its net profit margin was -483.57, with a year-on-year change of 99.46.

What is the debt-to-asset ratio of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 9.36, with a year-on-year change of 237.61.

What is the Return on Equity (ROE) of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -63.87, with a year-on-year change of 15.03.

What is the Return on Assets (ROA) of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -41.73, with a year-on-year change of 4.70.

What is the operating profit of Viridian Therapeutics Inc?

According to Viridian Therapeutics Inc's FY2025 earnings report, its operating profit was -324.92M, with a year-on-year change of -8.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.